NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 1 filers reported holding NOVUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $32,000 | – | 32,988 | +412250.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 8 | -98.2% | 0.00% | – |
| Q1 2019 | $2,000 | -33.3% | 442 | -21.6% | 0.00% | – |
| Q3 2018 | $3,000 | – | 564 | +28100.0% | 0.00% | – |
| Q2 2018 | $0 | – | 2 | -97.1% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 68 | -84.7% | 0.00% | – |
| Q2 2017 | $3,000 | – | 445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 80,069 | $1,233,000 | 0.56% |